FCMV
Foresite Capital Management V Portfolio holdings
AUM
$164M
1-Year Est. Return
103.09%
This Fund
S&P 500
1 Year Est. Return
+103.09%
AUM
$164M
AUM Growth
+$55.7M
(+51%)
Holding
7
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
1
Alumis Inc
ALMS
$3.51B
| $56.4M | 34.31% |
5,779,348
|
|
||
2
CG Oncology
CGON
$5B
| $41.7M | 25.36% |
1,004,050
|
|
||
3
Disc Medicine
IRON
$2.43B
| $23.7M | 14.45% |
299,069
|
|
||
4
Natera
NTRA
$27.9B
| $15.4M | 9.39% |
+67,356
|
|
||
5
Lyell Immunopharma
LYEL
$512M
| $14.7M | 8.93% |
477,078
|
|
||
6
Hims & Hers Health
HIMS
$3.61B
| $8.87M | 5.39% |
273,151
|
|
||
|
MAZE
7
Maze Therapeutics
MAZE
$2.19B
| $3.58M | 2.17% |
86,291
|
|